198 related articles for article (PubMed ID: 7534192)
21. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
[TBL] [Abstract][Full Text] [Related]
22. Update on antiretroviral therapy of HIV infection.
Vella S
J Biol Regul Homeost Agents; 1994; 8(3):71-6. PubMed ID: 7754791
[TBL] [Abstract][Full Text] [Related]
23. HIV resistance: the new enemy.
Colvin R
Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845
[TBL] [Abstract][Full Text] [Related]
24. New nonnucleoside reverse transcriptase inhibitors.
GMHC Treat Issues; 1999 Feb; 13(2):10. PubMed ID: 11366114
[TBL] [Abstract][Full Text] [Related]
25. Current approaches to treatment for HIV-1 infection.
Powderly WG
J Neurovirol; 2000 May; 6 Suppl 1():S8-S13. PubMed ID: 10871760
[TBL] [Abstract][Full Text] [Related]
26. Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors.
Saracino A; Monno L; Scudeller L; Cibelli DC; Tartaglia A; Punzi G; Torti C; Lo Caputo S; Mazzotta F; Scotto G; Carosi G; Angarano G
J Med Virol; 2006 Jan; 78(1):9-17. PubMed ID: 16299731
[TBL] [Abstract][Full Text] [Related]
27. Resistance of HIV-1 to multiple antiretroviral drugs in France: a 6-year survey (1997-2002) based on an analysis of over 7000 genotypes.
Tamalet C; Fantini J; Tourres C; Yahi N
AIDS; 2003 Nov; 17(16):2383-8. PubMed ID: 14571191
[TBL] [Abstract][Full Text] [Related]
28. Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1.
Turner D; Brenner B; Wainberg MA
J Antimicrob Chemother; 2004 Jan; 53(1):53-7. PubMed ID: 14645322
[TBL] [Abstract][Full Text] [Related]
29. New non-nucleoside reverse transcriptase inhibitors (NNRTIs) in development for the treatment of HIV infections.
Pauwels R
Curr Opin Pharmacol; 2004 Oct; 4(5):437-46. PubMed ID: 15351347
[TBL] [Abstract][Full Text] [Related]
30. Resistance to non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Bacheler LT
Drug Resist Updat; 1999 Feb; 2(1):56-67. PubMed ID: 11504469
[TBL] [Abstract][Full Text] [Related]
31. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
Martinez-Picado J; MartÃnez MA
Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
[TBL] [Abstract][Full Text] [Related]
32. An introduction to nucleoside and nucleotide analogues.
Squires KE
Antivir Ther; 2001; 6 Suppl 3():1-14. PubMed ID: 11678469
[TBL] [Abstract][Full Text] [Related]
33. The effect of NNRTIs on HIV reverse transcriptase dimerization.
Tachedjian G; Goff SP
Curr Opin Investig Drugs; 2003 Aug; 4(8):966-73. PubMed ID: 14508881
[TBL] [Abstract][Full Text] [Related]
34. Modest decreases in NNRTI susceptibility do not influence virological outcome in patients receiving initial NNRTI-containing triple therapy.
Harrigan PR; Hertogs K; Verbiest W; Larder B; Yip B; Brumme ZL; Alexander C; Tilley J; O'Shaughnessy MV; Montaner JS
Antivir Ther; 2003 Oct; 8(5):395-402. PubMed ID: 14640386
[TBL] [Abstract][Full Text] [Related]
35. New antiretroviral drugs, part II: NRTIs, NNRTIs, and beyond.
Murphy RL
AIDS Clin Care; 1999 Jun; 11(6):47-9, 51, 53-4. PubMed ID: 11366882
[TBL] [Abstract][Full Text] [Related]
36. Non-nucleoside reverse transcriptase inhibitors.
Bowers M
BETA; 1996 Jun; ():19-22. PubMed ID: 11363645
[TBL] [Abstract][Full Text] [Related]
37. [Current acquisitions in antiviral drugs (anti-HIV)].
De Clercq E; Snoeck R
J Pharm Belg; 1992; 47(4):317-22. PubMed ID: 1383488
[TBL] [Abstract][Full Text] [Related]
38. Chemotherapeutic approaches to human immunodeficiency virus infections.
Baba M
Fukushima J Med Sci; 1992 Jun; 38(1):1-18. PubMed ID: 1284048
[TBL] [Abstract][Full Text] [Related]
39. Therapy other than reverse transcriptase inhibitors for HIV infection.
Kaplan JC; Hirsch MS
Clin Lab Med; 1994 Jun; 14(2):367-91. PubMed ID: 7523020
[TBL] [Abstract][Full Text] [Related]
40. Combining New Non-Nucleoside Reverse Transcriptase Inhibitors (RTIs) with AZT Results in Strong Synergism against Multi-RTI-Resistant HIV-1 Strains.
Yu F; Li W; Wang L; Dai Y; Lu X; Wang Q; Xie L; Jiang S
Molecules; 2018 Jul; 23(7):. PubMed ID: 30004408
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
